A5084187725- Hepatocellular Carcinoma Treatment and Prognosis
- Cell death mechanisms and regulation
- Colorectal Cancer Treatments and Studies
- HVDC Systems and Fault Protection
- Gastric Cancer Management and Outcomes
- Cancer Mechanisms and Therapy
- Virus-based gene therapy research
- Pancreatic and Hepatic Oncology Research
- Cancer-related gene regulation
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Molecular Biology Techniques and Applications
- Cancer-related Molecular Pathways
- RNA modifications and cancer
The mixed lineage kinase domain‑like protein (MLKL), which is a major mediator of the necroptosis pathway, involved in certain cancers. present study aimed to explore expression patterns and exact role MLKL gastric cancer (GC) tumorigenesis progression. In Cancer Cell Line Encyclopedia analysis, mRNA levels GC cell lines were not higher compared with that other lines. results demonstrated was decreased tissues normal tissues. Kaplan‑Meier Plotter database survival analyses, associated poor...
Lian Lian, Xue-Fei Xu, Xiao-Ming Shen, Tie-Ao Huang, Xian-Min Li, Shu-Guang Han, Chong Zhou, You-You Xia
To optimize treatment, choosing the appropriate relative dose intensity (RDI) of nab-paclitaxel is an important way to improve patient tolerance, therapeutic efficacy, and survival. However, few studies have focused on efficacy RDI in patients with advanced pancreatic cancer, whether could be employed as index for treatment remains unknown. explore relationship between chemotherapy survival, quality life (QoL), adverse effects cancer.In this retrospective study, a total 32 ECOG score 0 2...